SCHEMBL3789405

SCHEMBL3789405

Nc1ccc(-c2ccccc2)cc1C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.48
FFAR4 Q5NUL3 1/20 0.47
HSD17B10 Q99714 3/20 0.47
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 1/20 0.47
USP2 O75604 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
HSP90AA1 P07900 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
ALOX12 P18054 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
ACHE P22303 4/20 0.46
IKBKB O14920 1/20 0.46
HDAC2 Q92769 3/20 0.44
PGR P06401 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29403371 0.89 KIF11 (0.50) KIF11FFAR4HSD17B10MEN1ALDH1A1
SCHEMBL349356 0.89 KIF11 (0.50) KIF11FFAR4HSD17B10MEN1ALDH1A1
Hydrochloric Acid SCHEMBL8644024 0.87 KIF11 (0.48) KIF11FFAR4HSD17B10MEN1ALDH1A1
SCHEMBL1011734 0.86 KIF11 (0.63) KIF11FFAR4HSD17B10MEN1ALDH1A1
SCHEMBL3792886 0.85 MAOA (0.50) KIF11MEN1GAAPGRMAOA
SCHEMBL3785824 0.84 KIF11 (0.57) KIF11HSD17B10KDM4EMEN1USP2
Water SCHEMBL28831861 0.84 KIF11 (0.61) KIF11FFAR4HSD17B10MEN1ALDH1A1
SCHEMBL31570062 0.84 KIF11 (0.57) KIF11HSD17B10KDM4EMEN1USP2
SCHEMBL8922815 0.82 KIF11 (0.54) KIF11FFAR4HSD17B10MEN1ALDH1A1
SCHEMBL4779653 0.81 RXRA (0.58) KIF11RXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025100475-A1 COMPOSITION FOR IMAGE RECORDING AND METHOD FOR PRODUCING SAME キヤノン株式会社 2025-05-15 WO disclosed
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed
US-4731450-A Process for perfluoroalkylation of aromatic derivatives RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1988-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 KIF11 3999/4885FFAR4 4051/4885HSD17B10 1100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.